pwshub.com

Melanoma Pioneer's Self-Applied Treatment Eradicates Brain Cancer

Melanoma Pioneer's Self-Applied Treatment Eradicates Brain Cancer
Melanoma Pioneer's Self-Applied Treatment Eradicates Brain Cancer

An Australian doctor who applied his own pioneering research on melanoma to the incurable brain cancer he was diagnosed with almost a year ago is still cancer-free.

Professor Richard Scolyer said he "couldn't be happier" after the results of a recent MRI showed there was still no sign of recurrence of his glioblastoma.

He became the world's first brain cancer patient to have pre-surgery combination immunotherapy as he used the foundation of his life-changing work on melanoma on himself.

Professor Scolyer is now hopeful the tumor will not return as, according to the doctor, the median time to recurrence for the grade four brain tumor he had is six months.

"By undertaking an experimental treatment with risk of shortening his life, he has advanced the understanding of brain cancer and is benefiting future patients," the University of Sydney said as it announced the Australians Of The Year award for Prof Scolyer and Prof Long.

The professors, who are also co-medical directors of the Melanoma Institute Australia, made the disease a curable one thanks to their immunotherapy approach, which activates a patient's own immune system.

Speaking to Sky News's Kay Burley back in February, Prof Scolyer said the "risk of major adverse reactions to these sorts of drugs is fairly high, but I've had it plain-sailing so far so I couldn't be happier and I hope it stays like that for some time longer".

Prof Long added: "We've shown that... you can activate the immune system and do it very well and this is now a foundational first step to change the field and the way drugs are explo

newsid: 5q5p8zlsv3wuvbd

Related stories
4 hours ago - According to BrainTumor.org, those diagnosed with Glioblastoma have an average survival rate of only 6.9%, with the length of survival estimated to be less than a year. One local patient is beating the odds, and still going strong.
8 hours ago - With the week ahead beckoning, check out some of the top recent stories in Health that you may have missed, or have been meaning to check out — here are 7 key developments.
15 hours ago - The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of four teams in 2001 that found and described the mammalian sweet taste receptor—TAS1R2-TAS1R3. ...
1 day ago - A new study found that certain vegetarian and vegan diets curb risks of life-threatening illnesses like cancer and heart disease.
2 days ago - NIH researchers suggest conducting nail evaluation of affected patients and at-risk family members
Other stories
2 minutes ago - A new study indicates that face masks did not significantly lower Covid-19 infection risk after the initial Omicron wave, highlighting the need for adaptable strategies and further research as risk factors evolve. New findings from the University of East Anglia suggest that wearing face masks did n
50 minutes ago - 'WSJ:' Neuroscientist volunteers herself for study, resulting in first-of-its-kind discoveries
50 minutes ago - If you search the words "how to edge" on Google, the words "in class" are recommended as the top autocomplete suggestion.
2 hours ago - Many patients who died after traumatic brain injuries may have survived and recovered if their families had waited to take them off life support, a new study found.
3 hours ago - How to Do It I see a sultry slutty summer in my future … and maybe even a side-hustle? Photo illustration by Slate. Photo by...